India Glycols Limited will conduct its 42nd Annual General Meeting (AGM) on Wednesday, August 19, 2026, at 11:00 AM IST. The meeting will be held through Video Conferencing and Other Audio Visual Means (VC/OAVM) to ensure shareholder participation in compliance with the Companies Act, 2013 and relevant circulars issued by the Ministry of Corporate Affairs. This digital format allows shareholders to attend remotely and participate in the proceedings concerning the financial year 2025-26.

The Notice of the 42nd AGM and the Annual Report for the Financial Year 2025-26 will be disseminated to shareholders. These documents will be sent by email to those shareholders whose email addresses are registered with the company, its Registrar and Transfer Agent (RTA), or Depository Participants. The documentation will include detailed instructions for e-voting and attending the AGM via the VC/OAVM platform.

In compliance with Regulation 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company is ensuring broad access to the Annual Report. A letter containing a web-link and the exact path to access the Annual Report for FY 2025-26 will be sent specifically to shareholders whose email addresses are not currently registered with the company, RTA, or Depository Participants.

The Annual Report and related documents will also be hosted on the official website of India Glycols Limited . Shareholders can access the report at www.indiaglycols.com once it is made available. The filing was signed by Ankur Jain, Head (Legal) & Company Secretary, on July 22, 2026.

Key Meeting Details

India Glycols Limited secured approval from the National Company Law Tribunal (NCLT), Allahabad Bench at Prayagraj, for its demerger scheme on July 17, 2026. The order sanctions the Scheme of Arrangement involving the demerger of the Bio Pharma Undertaking into Ennature Bio Pharma Limited and the Spirits and Biofuel Undertaking into IGL Spirits Limited. This restructuring separates the company's distinct business verticals into separate resulting entities. The Appointed Date of the Scheme is April 1, 2026, while the company will inform the stock exchanges separately about the Effective Date.

The scheme was executed pursuant to the provisions of Section 230 to 232 of the Companies Act, 2013. The approval follows an earlier intimation dated July 3, 2026, regarding the hearing before the tribunal. The certified copy of the order was uploaded on the NCLT website on July 20, 2026. The requisite steps in compliance of the said order are being taken by the company, Ennature Bio Pharma Limited and IGL Spirits Limited.

Details of the Scheme

The arrangement involves three entities: India Glycols Limited as the Demerged Company, Ennature Bio Pharma Limited as Resulting Company 1, and IGL Spirits Limited as Resulting Company 2. The scheme facilitates the transfer of specific undertakings to these new entities.

Upon the Scheme becoming effective, the Bio Pharma and the Spirits and Biofuel Undertaking(s) will be transferred to and vested in Ennature Bio Pharma Limited and IGL Spirits Limited, respectively. The disclosure was made to the BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ankur Jain, Head (Legal) & Company Secretary of India Glycols Limited.